Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00473070 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study of Tobradex AF
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 900
- Enrollment target
NCT00473070 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 900 participants.
The verdict
NCT00473070, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 900 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.
Interventions
- DRUG Tobradex AF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2006-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00473070
The ClinicalTrials.gov registry entry for NCT00473070 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tobradex AF is the first listed.
NCT00473070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00473070 about?
NCT00473070 is a clinical study titled "A Clinical Study of Tobradex AF". The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.
What is the current status of trial NCT00473070?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 900 participants. The study started on 2006-11.
What interventions are being tested in trial NCT00473070?
The interventions under investigation include: Tobradex AF (DRUG).
Who is sponsoring clinical trial NCT00473070?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.